Liu et al. previously established a murine model of ITP in pregnancy by administering anti-GPIIb/IIIa antibody and showed efficacy and safety of recombinant human TPO (rhTPO) [7]. This evidence concerns the gene ITGA2B and autoimmune thrombocytopenic purpura.